This Article Full Text Full Text (PDF) All Versions of this Article: 90/10/5536    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stubbs, S. A. Articles by Franks, S. Search for Related Content PubMed PubMed Citation Articles by Stubbs, S. A. Articles by Franks, S. Related Collections Female Endocrinology

Anti-Müllerian Hormone Protein Expression Is Reduced during the Initial Stages of Follicle Development in Human Polycystic Ovaries

Institute of Reproductive and Developmental Biology (S.A.S., K.H., P.D.S.-B., L.J.W., S.F.), Wolfson and Weston Research Centre for Family Health, Imperial College London, Hammersmith Hospital, London W12 0NN, United Kingdom; Department of Mathematics (J.S.), Imperial College London, London SW7 2AZ, United Kingdom; Histopathology Department (A.M.F.), Division of Investigative Sciences, Imperial College London, St. Mary’s Hospital, London W2 1PG, United Kingdom; Department of Internal Medicine (A.P.N.T., J.A.V.), Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands; and School of Biological and Molecular Sciences (N.P.G.), Oxford Brookes University, Headington Campus, Oxford OX3 0BP, United Kingdom

Address all correspondence and requests for reprints to: Kate Hardy, Institute of Reproductive and Developmental Biology, Wolfson and Weston Research Centre for Family Health, Imperial College London, Hammersmith Hospital, London W12 0NN, United Kingdom. E-mail: k.hardy{at}imperial.ac.uk.

Context: Polycystic ovary syndrome, the most common cause of anovulatory infertility, is characterized by disordered folliculogenesis, notably increased progression from the primordial to the primary stages. This ovarian phenotype is similar to that observed in mice lacking anti-müllerian hormone (AMH).

Objective: The objective of this study is to investigate whether AMH is involved in accelerating the transition of follicles from primordial to primary stages in polycystic ovaries.

Design: This study compares AMH expression in archive tissue from normal and polycystic ovaries.

Setting: This is a laboratory-based study.

Patients: Ovarian tissue from seven normoovulatory women and 16 women with polycystic ovaries (five of whom were anovulatory) was used in this study. Ovaries were classified by histology and with reference to menstrual cycle history and ultrasound.

Main Outcome Measure: Presence and intensity of AMH expression in 1403 follicles was the main outcome measure.

Results: AMH was observed from the primordial stage onward. AMH immunostaining was observed in significantly fewer primordial (P = 0.007) and transitional follicles (P = 0.001) in ovaries from anovulatory women with polycystic ovaries compared with women with regular cycles and either normal or polycystic ovaries. AMH-negative follicles had fewer pregranulosa cells in the largest cross-section of the follicle at both the primordial (median, four and six for AMH-negative and -positive follicles, respectively; P < 0.0001) and transitional stages (median six and nine; P < 0.0007) in normal tissue, and fewer at the transitional stage (median, seven and 11; P < 0.0001) in tissue from anovulatory women with polycystic ovaries. This suggests that AMH expression is associated with granulosa cell mitosis.

Conclusions: These findings indicate a relative deficiency of AMH in primordial and transitional follicles in ovaries from anovulatory women with polycystic ovaries. This may contribute to disordered early follicle development in polycystic ovary syndrome.

This article has been cited by other articles:

				A I Qureshi, S S Nussey, G Bano, P Musonda, S A Whitehead, and H D Mason Testosterone selectively increases primary follicles in ovarian cortex grafted onto embryonic chick membranes: relevance to polycystic ovaries Reproduction, August 1, 2008; 136(2): 187 - 194. [Abstract] [Full Text] [PDF]

				S. Franks, J. Stark, and K. Hardy Follicle dynamics and anovulation in polycystic ovary syndrome Hum. Reprod. Update, May 22, 2008; (2008) dmn015v1. [Abstract] [Full Text] [PDF]

				P.A Johnson, T.R Kent, M.E Urick, and J.R Giles Expression and Regulation of Anti-Mullerian Hormone in an Oviparous Species, the Hen Biol Reprod, January 1, 2008; 78(1): 13 - 19. [Abstract] [Full Text] [PDF]

				S. A. Stubbs, J. Stark, S. M. Dilworth, S. Franks, and K. Hardy Abnormal Preantral Folliculogenesis in Polycystic Ovaries Is Associated with Increased Granulosa Cell Division J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4418 - 4426. [Abstract] [Full Text] [PDF]

				D. S. Wachs, M. S. Coffler, P. J. Malcom, and R. J. Chang Serum Anti-Mullerian Hormone Concentrations Are Not Altered by Acute Administration of Follicle Stimulating Hormone in Polycystic Ovary Syndrome and Normal Women J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1871 - 1874. [Abstract] [Full Text] [PDF]

				L. J. Webber, S. A. Stubbs, J. Stark, R. A. Margara, G. H. Trew, S. A. Lavery, K. Hardy, and S. Franks Prolonged Survival in Culture of Preantral Follicles from Polycystic Ovaries J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1975 - 1978. [Abstract] [Full Text] [PDF]

				F. H. Thomas, E. E. Telfer, and H. M. Fraser Expression of Anti-Mullerian Hormone Protein during Early Follicular Development in the Primate Ovary in Vivo Is Influenced by Suppression of Gonadotropin Secretion and Inhibition of Vascular Endothelial Growth Factor Endocrinology, May 1, 2007; 148(5): 2273 - 2281. [Abstract] [Full Text] [PDF]

				R. L. Rosenfield Identifying Children at Risk for Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 787 - 796. [Abstract] [Full Text] [PDF]

				S. Rice, K. Ojha, S. Whitehead, and H. Mason Stage-Specific Expression of Androgen Receptor, Follicle-Stimulating Hormone Receptor, and Anti-Mullerian Hormone Type II Receptor in Single, Isolated, Human Preantral Follicles: Relevance to Polycystic Ovaries J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1034 - 1040. [Abstract] [Full Text] [PDF]

				G. Meduri, N. Massin, J. Guibourdenche, A. Bachelot, O. Fiori, F. Kuttenn, M. Misrahi, and P. Touraine Serum anti-Mullerian hormone expression in women with premature ovarian failure Hum. Reprod., January 1, 2007; 22(1): 117 - 123. [Abstract] [Full Text] [PDF]

				D. Modi, D. Bhartiya, and C. Puri Developmental expression and cellular distribution of Mullerian inhibiting substance in the primate ovary. Reproduction, September 1, 2006; 132(3): 443 - 453. [Abstract] [Full Text] [PDF]

				T. Sir-Petermann, E. Codner, M. Maliqueo, B. Echiburu, C. Hitschfeld, N. Crisosto, F. Perez-Bravo, S. E. Recabarren, and F. Cassorla Increased Anti-Mullerian Hormone Serum Concentrations in Prepubertal Daughters of Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3105 - 3109. [Abstract] [Full Text] [PDF]